Author Question: To prevent Rh isoimmunization, RhIG (RhoGAM) is administered to all: a. Rh-negative women who ... (Read 16 times)

sabina

  • Hero Member
  • *****
  • Posts: 563
To prevent Rh isoimmunization, RhIG (RhoGAM) is administered to all:
 
  a. Rh-negative women who deliver an Rh-positive newborn.
  b. Rh-positive women who deliver an Rh-negative newborn.
  c. Rh-negative newborns whose mothers are Rh positive.
  d. Rh-positive fathers before conception of second newborn when first newborn was Rh positive.

Question 2

Which is the primary treatment for hypoglycemia in newborns with feeding intolerance?
 
  a. Oral glucose feedings
  b. Intravenous (IV) infusion of glucose
  c. Short-term insulin therapy
  d. Feedings (formula or breast milk) at least every 2 hours



fur

  • Sr. Member
  • ****
  • Posts: 309
Answer to Question 1

ANS: A
Rh IG human gamma globulin concentrate of anti-D is administered to all unsensitized Rh-negative women after delivery or abortion of an Rh-positive newborn or fetus. Administering RhIG to an individual who is Rh positive will result in agglutination of red cells and hemolysis. It will not alter the person's genetic makeup. The anti-D antibody contained in RhIG will have no effect on Rh-negative newborns because the D antibody is not present.

Answer to Question 2

ANS: B
IV infusions of glucose are indicated when the glucose level is very low and when feedings are not tolerated. Early feedings in the normoglycemic newborn are preventive. When the newborn is unable to tolerate feedings or the blood glucose level has become extremely low, then IV infusions are indicated. Insulin administration will further depress the blood glucose level. Feedings can be preventive. The child may not be able to tolerate this frequency.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

For a complete list of videos, visit our video library